Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Consulting agrmnt
Inv. presentation
|
|
Eloxx Pharmaceuticals, Inc. (ELOX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/16/2021 |
8-K/A
| Financial Statements and Exhibits Interactive Data|
Docs:
|
"CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in Registration Statement No. 333-228430 on Form S-3 and Registration Statement Nos. 333-254201, 333-236952, 333-224860, 333-222499, and 333-201891 on Form S-8 of our report dated June 16, 2021, relating to the financial statements of Zikani Therapeutics, Inc. for the years ended December 31, 2020 and 2019, appearing in this current report on Form 8-K/A of Eloxx Pharmaceuticals, Inc. /s/ Moody, Famiglietti & Andronico, LLP",
"Independent Auditors’ Report",
"ZIKANI THERAPEUTICS, INC. Index to Unaudited Interim Condensed Financial Statements CONDENSED FINANCIAL STATEMENTS CONDENSED BALANCE SHEET 2 CONDENSED STATEMENT OF OPERATIONS 3 CONDENSED STATEMENT OF CASH FLOWS 4 CONDENSED STATEMENT OF CHANGES IN CONVERTIBLE PREFERRRED STOCK AND STOCKHOLDERS’ DEFICIT 5 NOTES TO FINANCIAL STATEMENTS 6 ZIKANI THERAPEUTICS, INC. UNAUDITED CONDENSED BALANCE SHEET",
"UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION" |
|
| 03/13/2020 |
8-K/A
| Quarterly results |
| 06/21/2019 |
8-K/A
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
| 03/16/2018 |
8-K/A
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 03/08/2018 |
8-K/A
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year |
| 07/25/2014 |
8-K/A
| Financial Statements and Exhibits|
Docs:
|
"Consent of Mayer Hoffman McCann P.C., Independent Accountants for Fabrus, Inc",
"Audited financial statements of Fabrus, Inc. as of and for the years ended December 31, 2013 and 2012 and for the period from July 13, 2007 (Inception) through December 31, 2013 and unaudited condensed financial statements of Fabrus, Inc. as of and for three months ended March 31, 2014 and 2013 and for the period from July 13, 2007 (Inception) through March 31, 2014",
"Unaudited pro forma condensed combined consolidated balance sheet as of March 31, 2014; and unaudited pro forma condensed combined statements of operations for the fiscal year ended June 30, 2013 and for the nine months ended March 31, 2014" |
|
| 04/08/2010 |
8-K/A
| Form 8-K/A - Current report [Amend] |
| 11/28/2007 |
8-K/A
| Form 8-K/A - Current report [Amend] |
| 11/20/2007 |
8-K/A
| Form 8-K/A - Current report [Amend] |
| 11/01/2007 |
8-K/A
| Form 8-K/A - Current report [Amend] |
| 11/15/2006 |
8-K/A
| Form 8-K/A - Current report [Amend] |
|
|